Actionable insights straight to your inbox

logo_equities.svg

An Application for the Trademark “GILEAD ACCESSCONNECT” Has Been Filed by Gilead Sciences

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for

By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “GILEAD ACCESSCONNECT” by Gretchen R. Stroud, representing Gilead Sciences. This application was made available to the public on June 26, 2014 (see also Trademarks).
The serial number for this application is 86230465.
The international trademark goods and services class code for this trademark application is 044.
As submitted by the applicant, this trademark application relates to the following goods and services: Providing health and medical information by telephone and the internet; counseling and charitable services for patients, namely providing information and assistance with respect to obtaining prescription medications.
The owner/registrar information for this application is: Gretchen R. Stroud, Gilead Sciences, 333 Lakeside Dr, Foster City, CA 94404-1147.
Keywords for this news article include: Trademarks, Gilead Sciences, Biotechnology Companies, Biopharmaceutical Companies.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

Many people think of position size in terms of how many shares they own of a particular stock. But it’s much smarter to think of it in terms of what percentage of your total capital is in a particular stock.